Tickers — I

61 tickers
Ranks this page's recent reports by score.
IQVIA Holdings Inc.
IQV·Healthcare
A ★★★★Buy
Current$275.06
Target$299.25
Return+8.8%
Oct 30, 2026

IQVIA combines durable clinical research outsourcing demand, differentiated healthcare data assets, and improving earnings momentum, although substantial leverage and clinical backlog execution risks limit its margin of safety.

Score
77
Invesco Ltd.
IVZ·Financials
A ★★★★Buy
Current$29.02
Target$34.44
Return+18.7%
Oct 30, 2026

Invesco offers attractive normalized earnings valuation, improving margins and ETF-driven growth, although market-sensitive AUM, fee compression and floating-rate financing could limit sustainable returns.

Score
75
InterContinental Hotels Group PLC
IHG·Consumer Discretionary
A ★★★★Buy
Current$162.40
Target$171.60
Return+5.7%
Oct 26, 2026

IHG's asset-light hotel franchise network, durable brands and growing room pipeline support attractive long-term earnings compounding, although premium valuation and rising financing costs constrain near-term upside.

Score
76
Infosys Limited
INFY·Technology
A ★★★★Buy
Current$12.35
Target$14.08
Return+14.0%
Oct 26, 2026

Infosys combines exceptional cash generation, high returns on capital, and a historically discounted valuation with an expanding AI-services opportunity, although sluggish enterprise spending and AI-driven pricing disruption constrain near-term growth.

Score
81
International Business Machines Corporation
IBM·Technology
B ★★★Hold
Current$253.56
Target$262.00
Return+3.3%
Oct 24, 2026

IBM's entrenched enterprise technology franchise and expanding software profitability support durable cash generation, but acquisition-related leverage, sluggish consulting demand, and limited valuation upside constrain returns.

Score
74
Interactive Brokers Group, Inc.
IBKR·Financials
B ★★★Hold
Current$82.28
Target$90.45
Return+9.9%
Oct 23, 2026

Interactive Brokers combines low-cost global brokerage infrastructure with rapid account growth and strong profitability, but its elevated historical valuation and sensitivity to interest income limit the margin of safety.

Score
69
Intuitive Surgical, Inc.
ISRG·Healthcare
A ★★★★Buy
Current$443.85
Target$460.56
Return+3.8%
Oct 23, 2026

Intuitive Surgical combines a dominant robotic-surgery ecosystem with recurring procedure revenue and strong cash generation, but its premium valuation and planned instrument-pricing reductions constrain near-term upside.

Score
82
Independent Bank Corp.
INDB·Financials
B ★★★Hold
Current$79.46
Target$91.80
Return+15.5%
Oct 20, 2026

Independent Bank offers improving regional-bank profitability, meaningful dividends, and moderate earnings valuation, but commercial real estate exposure and competitive deposit funding limit the margin of safety.

Score
74
ICICI Bank Limited
IBN·Financials
A ★★★★Buy
Current$29.58
Target$34.02
Return+15.0%
Oct 19, 2026

ICICI Bank combines a durable Indian deposit franchise, strong credit quality, and profitable long-term lending growth, although its premium valuation and recent net interest margin compression constrain the margin of safety.

Score
78
Samsara Inc.
IOT·Technology
C ★★Sell
Current$38.38
Sep 14, 2026

Samsara is a founder-led physical-operations SaaS platform compounding ARR near 30% with rising profitability, but premium multiples, heavy founder selling and concentrated voting control leave too little margin of safety at today's price.

Score
66
IREN Limited
IREN·Financials
A ★★★★Buy
Current$35.45
Target$76.13
Return+114.7%
Aug 30, 2026

IREN's integrated AI infrastructure and gigawatt-scale power assets offer undervalued exposure to hyperscaler demand, but its vast data center construction pipeline brings high volatility and execution risk.

Score
93